Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWUXK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $129,235
Award facts
- Contract value 100% obligated
- $129,234.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, valued at approximately $129,000, carries an ultimate completion date of October 20, 2025, and was awarded on September 26, 2025. This delivery order does not utilize a set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that authorizes firm fixed-price orders for pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables essential to Department of Defense healthcare operations. The company's positioning as the sole awardee on this substantial IDC reflects its capability to deliver a comprehensive range of pharmaceutical products to military medical facilities across the globe.
Quick answers
Who was awarded contract SPE2DB25FWUXK?
SPE2DB25FWUXK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWUXK worth?
The government has obligated $129,235 on SPE2DB25FWUXK.
Is contract SPE2DB25FWUXK an order under another contract?
Yes. SPE2DB25FWUXK is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUXK competed?
The extent of competition for SPE2DB25FWUXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award